 | • レポートコード：MRC2-11QY04906 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は腫瘍マーカー検査のグローバル市場について調査・分析したレポートです。種類別（生化学的マーカー、癌遺伝子、成長因子、ホルモン、コロニー刺激因子、リンホカイン、免疫組織化学的染色、その他）市場規模、用途別（病院、商業/民間研究所、診療所/グループ診療所、がんクリニック、外来診療センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別腫瘍マーカー検査の競争状況、市場シェア ・世界の腫瘍マーカー検査市場：種類別市場規模 2015年-2020年（生化学的マーカー、癌遺伝子、成長因子、ホルモン、コロニー刺激因子、リンホカイン、免疫組織化学的染色、その他） ・世界の腫瘍マーカー検査市場：種類別市場規模予測 2021年-2026年（生化学的マーカー、癌遺伝子、成長因子、ホルモン、コロニー刺激因子、リンホカイン、免疫組織化学的染色、その他） ・世界の腫瘍マーカー検査市場：用途別市場規模 2015年-2020年（病院、商業/民間研究所、診療所/グループ診療所、がんクリニック、外来診療センター） ・世界の腫瘍マーカー検査市場：用途別市場規模予測 2021年-2026年（病院、商業/民間研究所、診療所/グループ診療所、がんクリニック、外来診療センター） ・北米の腫瘍マーカー検査市場分析：米国、カナダ ・ヨーロッパの腫瘍マーカー検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの腫瘍マーカー検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の腫瘍マーカー検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの腫瘍マーカー検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Diagnostics、Affymetrix、Agilent Technologies、Beckman，Dickinson（BD）、BioCurex、BioModa、Clarient、Correlogic Systems、Epigenomics、Hologic、Roche Diagnostics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.
During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
Market Analysis and Insights: Global Tumor Marker Testing Market
The global Tumor Marker Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tumor Marker Testing Scope and Market Size
Tumor Marker Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Marker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Diagnostics
Affymetrix
Agilent Technologies
Beckman，Dickinson（BD）
BioCurex
BioModa
Clarient
Correlogic Systems
Epigenomics
Hologic
Roche Diagnostics
Market segment by Type, the product can be split into
Biochemical Markers
Oncogenes
Growth Factors
Hormones
Colony Stimulating Factors
Lymphokines
Immunohistochemical Stains
Others
Market segment by Application, split into
Hospitals
Commercial/Private Laboratories
Physician Offices/Group Practices
Cancer Clinics
Ambulatory Care Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tumor Marker Testing Revenue
1.4 Market by Type
1.4.1 Global Tumor Marker Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Biochemical Markers
1.4.3 Oncogenes
1.4.4 Growth Factors
1.4.5 Hormones
1.4.6 Colony Stimulating Factors
1.4.7 Lymphokines
1.4.8 Immunohistochemical Stains
1.4.9 Others
1.5 Market by Application
1.5.1 Global Tumor Marker Testing Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Commercial/Private Laboratories
1.5.4 Physician Offices/Group Practices
1.5.5 Cancer Clinics
1.5.6 Ambulatory Care Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Tumor Marker Testing Market Perspective (2015-2026)
2.2 Global Tumor Marker Testing Growth Trends by Regions
2.2.1 Tumor Marker Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tumor Marker Testing Historic Market Share by Regions (2015-2020)
2.2.3 Tumor Marker Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tumor Marker Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Tumor Marker Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Tumor Marker Testing Players by Market Size
3.1.1 Global Top Tumor Marker Testing Players by Revenue (2015-2020)
3.1.2 Global Tumor Marker Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Tumor Marker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tumor Marker Testing Market Concentration Ratio
3.2.1 Global Tumor Marker Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tumor Marker Testing Revenue in 2019
3.3 Tumor Marker Testing Key Players Head office and Area Served
3.4 Key Players Tumor Marker Testing Product Solution and Service
3.5 Date of Enter into Tumor Marker Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tumor Marker Testing Historic Market Size by Type (2015-2020)
4.2 Global Tumor Marker Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Tumor Marker Testing Market Size by Application (2015-2020)
5.2 Global Tumor Marker Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Tumor Marker Testing Market Size (2015-2020)
6.2 Tumor Marker Testing Key Players in North America (2019-2020)
6.3 North America Tumor Marker Testing Market Size by Type (2015-2020)
6.4 North America Tumor Marker Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Tumor Marker Testing Market Size (2015-2020)
7.2 Tumor Marker Testing Key Players in Europe (2019-2020)
7.3 Europe Tumor Marker Testing Market Size by Type (2015-2020)
7.4 Europe Tumor Marker Testing Market Size by Application (2015-2020)
8 China
8.1 China Tumor Marker Testing Market Size (2015-2020)
8.2 Tumor Marker Testing Key Players in China (2019-2020)
8.3 China Tumor Marker Testing Market Size by Type (2015-2020)
8.4 China Tumor Marker Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Tumor Marker Testing Market Size (2015-2020)
9.2 Tumor Marker Testing Key Players in Japan (2019-2020)
9.3 Japan Tumor Marker Testing Market Size by Type (2015-2020)
9.4 Japan Tumor Marker Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Tumor Marker Testing Market Size (2015-2020)
10.2 Tumor Marker Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tumor Marker Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Tumor Marker Testing Market Size by Application (2015-2020)
11 India
11.1 India Tumor Marker Testing Market Size (2015-2020)
11.2 Tumor Marker Testing Key Players in India (2019-2020)
11.3 India Tumor Marker Testing Market Size by Type (2015-2020)
11.4 India Tumor Marker Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Tumor Marker Testing Market Size (2015-2020)
12.2 Tumor Marker Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Tumor Marker Testing Market Size by Type (2015-2020)
12.4 Central & South America Tumor Marker Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Diagnostics
13.1.1 Abbott Diagnostics Company Details
13.1.2 Abbott Diagnostics Business Overview
13.1.3 Abbott Diagnostics Tumor Marker Testing Introduction
13.1.4 Abbott Diagnostics Revenue in Tumor Marker Testing Business (2015-2020))
13.1.5 Abbott Diagnostics Recent Development
13.2 Affymetrix
13.2.1 Affymetrix Company Details
13.2.2 Affymetrix Business Overview
13.2.3 Affymetrix Tumor Marker Testing Introduction
13.2.4 Affymetrix Revenue in Tumor Marker Testing Business (2015-2020)
13.2.5 Affymetrix Recent Development
13.3 Agilent Technologies
13.3.1 Agilent Technologies Company Details
13.3.2 Agilent Technologies Business Overview
13.3.3 Agilent Technologies Tumor Marker Testing Introduction
13.3.4 Agilent Technologies Revenue in Tumor Marker Testing Business (2015-2020)
13.3.5 Agilent Technologies Recent Development
13.4 Beckman，Dickinson（BD）
13.4.1 Beckman，Dickinson（BD） Company Details
13.4.2 Beckman，Dickinson（BD） Business Overview
13.4.3 Beckman，Dickinson（BD） Tumor Marker Testing Introduction
13.4.4 Beckman，Dickinson（BD） Revenue in Tumor Marker Testing Business (2015-2020)
13.4.5 Beckman，Dickinson（BD） Recent Development
13.5 BioCurex
13.5.1 BioCurex Company Details
13.5.2 BioCurex Business Overview
13.5.3 BioCurex Tumor Marker Testing Introduction
13.5.4 BioCurex Revenue in Tumor Marker Testing Business (2015-2020)
13.5.5 BioCurex Recent Development
13.6 BioModa
13.6.1 BioModa Company Details
13.6.2 BioModa Business Overview
13.6.3 BioModa Tumor Marker Testing Introduction
13.6.4 BioModa Revenue in Tumor Marker Testing Business (2015-2020)
13.6.5 BioModa Recent Development
13.7 Clarient
13.7.1 Clarient Company Details
13.7.2 Clarient Business Overview
13.7.3 Clarient Tumor Marker Testing Introduction
13.7.4 Clarient Revenue in Tumor Marker Testing Business (2015-2020)
13.7.5 Clarient Recent Development
13.8 Correlogic Systems
13.8.1 Correlogic Systems Company Details
13.8.2 Correlogic Systems Business Overview
13.8.3 Correlogic Systems Tumor Marker Testing Introduction
13.8.4 Correlogic Systems Revenue in Tumor Marker Testing Business (2015-2020)
13.8.5 Correlogic Systems Recent Development
13.9 Epigenomics
13.9.1 Epigenomics Company Details
13.9.2 Epigenomics Business Overview
13.9.3 Epigenomics Tumor Marker Testing Introduction
13.9.4 Epigenomics Revenue in Tumor Marker Testing Business (2015-2020)
13.9.5 Epigenomics Recent Development
13.10 Hologic
13.10.1 Hologic Company Details
13.10.2 Hologic Business Overview
13.10.3 Hologic Tumor Marker Testing Introduction
13.10.4 Hologic Revenue in Tumor Marker Testing Business (2015-2020)
13.10.5 Hologic Recent Development
13.11 Roche Diagnostics
10.11.1 Roche Diagnostics Company Details
10.11.2 Roche Diagnostics Business Overview
10.11.3 Roche Diagnostics Tumor Marker Testing Introduction
10.11.4 Roche Diagnostics Revenue in Tumor Marker Testing Business (2015-2020)
10.11.5 Roche Diagnostics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Tumor Marker Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Tumor Marker Testing Revenue
Table 3. Ranking of Global Top Tumor Marker Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tumor Marker Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Biochemical Markers
Table 6. Key Players of Oncogenes
Table 7. Key Players of Growth Factors
Table 8. Key Players of Hormones
Table 9. Key Players of Colony Stimulating Factors
Table 10. Key Players of Lymphokines
Table 11. Key Players of Immunohistochemical Stains
Table 12. Key Players of Others
Table 13. Global Tumor Marker Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Tumor Marker Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Tumor Marker Testing Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Tumor Marker Testing Market Share by Regions (2015-2020)
Table 17. Global Tumor Marker Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Tumor Marker Testing Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Tumor Marker Testing Market Growth Strategy
Table 23. Main Points Interviewed from Key Tumor Marker Testing Players
Table 24. Global Tumor Marker Testing Revenue by Players (2015-2020) (Million US$)
Table 25. Global Tumor Marker Testing Market Share by Players (2015-2020)
Table 26. Global Top Tumor Marker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Marker Testing as of 2019)
Table 27. Global Tumor Marker Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Tumor Marker Testing Product Solution and Service
Table 30. Date of Enter into Tumor Marker Testing Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Tumor Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 33. Global Tumor Marker Testing Market Size Share by Type (2015-2020)
Table 34. Global Tumor Marker Testing Revenue Market Share by Type (2021-2026)
Table 35. Global Tumor Marker Testing Market Size Share by Application (2015-2020)
Table 36. Global Tumor Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 37. Global Tumor Marker Testing Market Size Share by Application (2021-2026)
Table 38. North America Key Players Tumor Marker Testing Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Tumor Marker Testing Market Share (2019-2020)
Table 40. North America Tumor Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 41. North America Tumor Marker Testing Market Share by Type (2015-2020)
Table 42. North America Tumor Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 43. North America Tumor Marker Testing Market Share by Application (2015-2020)
Table 44. Europe Key Players Tumor Marker Testing Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Tumor Marker Testing Market Share (2019-2020)
Table 46. Europe Tumor Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Tumor Marker Testing Market Share by Type (2015-2020)
Table 48. Europe Tumor Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Tumor Marker Testing Market Share by Application (2015-2020)
Table 50. China Key Players Tumor Marker Testing Revenue (2019-2020) (Million US$)
Table 51. China Key Players Tumor Marker Testing Market Share (2019-2020)
Table 52. China Tumor Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 53. China Tumor Marker Testing Market Share by Type (2015-2020)
Table 54. China Tumor Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 55. China Tumor Marker Testing Market Share by Application (2015-2020)
Table 56. Japan Key Players Tumor Marker Testing Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Tumor Marker Testing Market Share (2019-2020)
Table 58. Japan Tumor Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Tumor Marker Testing Market Share by Type (2015-2020)
Table 60. Japan Tumor Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Tumor Marker Testing Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Tumor Marker Testing Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Tumor Marker Testing Market Share (2019-2020)
Table 64. Southeast Asia Tumor Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Tumor Marker Testing Market Share by Type (2015-2020)
Table 66. Southeast Asia Tumor Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Tumor Marker Testing Market Share by Application (2015-2020)
Table 68. India Key Players Tumor Marker Testing Revenue (2019-2020) (Million US$)
Table 69. India Key Players Tumor Marker Testing Market Share (2019-2020)
Table 70. India Tumor Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 71. India Tumor Marker Testing Market Share by Type (2015-2020)
Table 72. India Tumor Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 73. India Tumor Marker Testing Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Tumor Marker Testing Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Tumor Marker Testing Market Share (2019-2020)
Table 76. Central & South America Tumor Marker Testing Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Tumor Marker Testing Market Share by Type (2015-2020)
Table 78. Central & South America Tumor Marker Testing Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Tumor Marker Testing Market Share by Application (2015-2020)
Table 80. Abbott Diagnostics Company Details
Table 81. Abbott Diagnostics Business Overview
Table 82. Abbott Diagnostics Product
Table 83. Abbott Diagnostics Revenue in Tumor Marker Testing Business (2015-2020) (Million US$)
Table 84. Abbott Diagnostics Recent Development
Table 85. Affymetrix Company Details
Table 86. Affymetrix Business Overview
Table 87. Affymetrix Product
Table 88. Affymetrix Revenue in Tumor Marker Testing Business (2015-2020) (Million US$)
Table 89. Affymetrix Recent Development
Table 90. Agilent Technologies Company Details
Table 91. Agilent Technologies Business Overview
Table 92. Agilent Technologies Product
Table 93. Agilent Technologies Revenue in Tumor Marker Testing Business (2015-2020) (Million US$)
Table 94. Agilent Technologies Recent Development
Table 95. Beckman，Dickinson（BD） Company Details
Table 96. Beckman，Dickinson（BD） Business Overview
Table 97. Beckman，Dickinson（BD） Product
Table 98. Beckman，Dickinson（BD） Revenue in Tumor Marker Testing Business (2015-2020) (Million US$)
Table 99. Beckman，Dickinson（BD） Recent Development
Table 100. BioCurex Company Details
Table 101. BioCurex Business Overview
Table 102. BioCurex Product
Table 103. BioCurex Revenue in Tumor Marker Testing Business (2015-2020) (Million US$)
Table 104. BioCurex Recent Development
Table 105. BioModa Company Details
Table 106. BioModa Business Overview
Table 107. BioModa Product
Table 108. BioModa Revenue in Tumor Marker Testing Business (2015-2020) (Million US$)
Table 109. BioModa Recent Development
Table 110. Clarient Company Details
Table 111. Clarient Business Overview
Table 112. Clarient Product
Table 113. Clarient Revenue in Tumor Marker Testing Business (2015-2020) (Million US$)
Table 114. Clarient Recent Development
Table 115. Correlogic Systems Business Overview
Table 116. Correlogic Systems Product
Table 117. Correlogic Systems Company Details
Table 118. Correlogic Systems Revenue in Tumor Marker Testing Business (2015-2020) (Million US$)
Table 119. Correlogic Systems Recent Development
Table 120. Epigenomics Company Details
Table 121. Epigenomics Business Overview
Table 122. Epigenomics Product
Table 123. Epigenomics Revenue in Tumor Marker Testing Business (2015-2020) (Million US$)
Table 124. Epigenomics Recent Development
Table 125. Hologic Company Details
Table 126. Hologic Business Overview
Table 127. Hologic Product
Table 128. Hologic Revenue in Tumor Marker Testing Business (2015-2020) (Million US$)
Table 129. Hologic Recent Development
Table 130. Roche Diagnostics Company Details
Table 131. Roche Diagnostics Business Overview
Table 132. Roche Diagnostics Product
Table 133. Roche Diagnostics Revenue in Tumor Marker Testing Business (2015-2020) (Million US$)
Table 134. Roche Diagnostics Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Marker Testing Market Share by Type: 2020 VS 2026
Figure 2. Biochemical Markers Features
Figure 3. Oncogenes Features
Figure 4. Growth Factors Features
Figure 5. Hormones Features
Figure 6. Colony Stimulating Factors Features
Figure 7. Lymphokines Features
Figure 8. Immunohistochemical Stains Features
Figure 9. Others Features
Figure 10. Global Tumor Marker Testing Market Share by Application: 2020 VS 2026
Figure 11. Hospitals Case Studies
Figure 12. Commercial/Private Laboratories Case Studies
Figure 13. Physician Offices/Group Practices Case Studies
Figure 14. Cancer Clinics Case Studies
Figure 15. Ambulatory Care Centers Case Studies
Figure 16. Tumor Marker Testing Report Years Considered
Figure 17. Global Tumor Marker Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Tumor Marker Testing Market Share by Regions: 2020 VS 2026
Figure 19. Global Tumor Marker Testing Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Tumor Marker Testing Market Share by Players in 2019
Figure 22. Global Top Tumor Marker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Marker Testing as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Tumor Marker Testing Revenue in 2019
Figure 24. North America Tumor Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Tumor Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Tumor Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Tumor Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Tumor Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Tumor Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Tumor Marker Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed
肝炎マーカー検査の世界市場（～2026年） The liver is an essential organ of the body which helps in digestion of food, removal of toxins from the blood, and storage of energy in the body. Inflammation of the liver usually due to viral infections, excessive alcohol consumption, and drugs can cause hepatitis. Hepatitis can be classified as h…- ヘルペスマーカー検査の世界市場（～2026年） Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial disea…
- 分子量マーカーの世界市場（～2026年） Molecular weight markers are used to calculate sample molecular weights in the medical research arena. In addition, these markers play a vital role in the monitoring of the progress of an electrophoretic run in separation and analysis of macromolecules. Molecular weight markers include RNA, DNA, and…
- 細胞表面マーカー検出の世界市場（～2026年） Cell surface markers are also known as cell surface antigen serves as monograms to help identify and classify cells. There is an increase in demand for the cell surface marker detection market owing to the advancements in high-throughput tools and techniques used for cytological analysis. Market Ana…
- 腫瘍マーカーイムノアッセイの世界市場（～2026年） Market Analysis and Insights: Global Tumor Markers Immunoassay Market The global Tumor Markers Immunoassay market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tumor Markers Immunoassay Scope and Market Size Tumor Markers I…